Drug-Approval

FDA Arthritis Drug Reviewer Jeffrey Siegel Joins Genentech After Approving Company Tocilizumab

2010-12-15 00:00:00 +0000 UTC | Importance: 7/10

Jeffrey Siegel, an FDA staff member specializing in arthritis drug reviews, oversaw the 2010 approval of Genentech tocilizumab (Actemra) for arthritis treatment. Within months of the approval, Siegel left the FDA to join Genentech and its parent company Roche as director of the division that …

Jeffrey Siegel FDA Genentech Roche Actemra regulatory-capture pharmaceutical-industry fda revolving-door drug-approval

FDA Approves OxyContin with Unsubstantiated Safety Claims

1995-12-20 00:00:00 +0000 UTC | Importance: 9/10

The FDA approved Purdue Pharma’s OxyContin application, including a scientifically unsubstantiated claim that delayed absorption ‘is believed to reduce the abuse liability of a drug.’ This approval occurred without clinical trials to prove the safety claim and marked the beginning …

FDA Purdue Pharma Dr. Curtis Wright Sackler Family regulatory-capture fda pharmaceuticals opioid-crisis revolving-door +1 more